XTL Biopharmaceuticals Ltd (XTLB) income statement
XTLBNasdaqPharmaceutical Preparations
$1.37−0.11 (-7.43%)
Close on Nov 20, 2026Market cap $12.96MP/E –Yield –
XTL Biopharmaceuticals Ltd financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $12.96MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | – | 0.67% | – | – | – | – | – | – | – | – | – | – |
| Operating margin | – | -171.8% | – | – | – | – | – | – | – | – | – | – |
| Pre-tax margin | – | 53.2% | – | – | – | – | – | – | – | – | – | – |
| Free cash flow margin | – | -370.7% | – | – | – | – | – | – | – | – | – | – |
| Effective tax rate | – | -54.2% | – | – | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||
| Return on equity | – | – | – | – | – | – | – | – | – | – | 0.04% | – |
| Return on invested capital | – | -14.9% | – | – | – | – | – | – | – | – | – | – |
| Return on capital employed | – | -18.1% | -24.7% | – | – | – | – | – | -27.8% | -95.3% | – | – |
| Return on total capital | – | -13.9% | – | – | – | – | – | – | – | – | – | – |
| NOPAT | -$1.33M | -$775.00K | -$604.35K | -$695.20K | -$814.49K | -$748.92K | -$665.18K | -$626.47K | -$984.34K | -$2.02M | -$2.85M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | – | -358.8% | – | – | – | – | – | – | – | – | – | – |
| OCF / Net income | – | – | – | – | – | – | – | – | – | – | -930.50 | – |
| FCF / OCF | – | 103.3% | – | – | – | 100.1% | 100.2% | – | – | 100.1% | 100.1% | – |
| FCF / Net income | – | – | – | – | – | – | – | – | – | – | -931.50 | – |
| FCF / EBITDA | – | – | – | – | – | – | – | – | – | 67.8% | 51.7% | – |
| Unlevered free cash flow | – | -$1.58M | – | – | – | $878.31K | -$433.63K | – | – | -$1.73M | -$1.85M | – |
| Levered free cash flow | – | -$1.67M | – | – | – | -$851.00K | -$910.00K | – | – | -$1.73M | -$1.86M | – |
| Efficiency | ||||||||||||
| Asset turnover | – | 0.08 | – | – | – | – | – | – | – | – | – | – |
| Fixed asset turnover | – | 2.41 | – | – | – | – | – | – | – | – | – | – |
| Receivables turnover | – | 4.56 | – | – | – | – | – | – | – | – | – | – |
| Days sales outstanding | – | 80.1 | – | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | – | 12.0% | – | – | – | – | – | – | – | – | – | – |
| CapEx to OCF | – | -3.3% | – | – | – | -0.12% | -0.22% | – | – | -0.12% | -0.11% | – |
| CapEx to depreciation | – | – | – | – | – | – | – | – | – | 0.67 | 0.29 | – |
| Liquidity | ||||||||||||
| Current ratio | – | 0.61 | 9.93 | – | – | – | – | – | 20.69 | 8.35 | – | – |
| Quick ratio | – | 0.61 | 9.93 | – | – | – | – | – | 20.69 | 8.35 | – | – |
| Cash ratio | – | 0.17 | 6.80 | – | – | – | – | – | 10.96 | 6.12 | – | – |
| Working capital | – | -$867.00K | $1.84M | – | – | – | – | – | $5.91M | $2.42M | – | – |
| Net current asset value | -$254.00K | -$1.78M | $1.84M | $3.62M | $4.95M | $3.23M | $6.13M | $6.89M | $3.24M | $2.42M | – | – |
| Leverage | ||||||||||||
| Total debt | – | $138.00K | – | – | – | – | – | – | – | – | – | – |
| Net debt | – | -$233.00K | – | – | – | – | – | – | – | – | – | – |
| Debt / Equity | – | 0.03 | – | – | – | – | – | – | – | – | – | – |
| Debt ratio | – | 1.6% | – | – | – | – | – | – | – | – | – | – |
| Assets to equity | -0.65 | 1.57 | 1.09 | 1.05 | 1.24 | 1.80 | 1.11 | 1.18 | 1.82 | 1.12 | – | – |
| Total debt / Capitalization | – | 2.5% | – | – | – | – | – | – | – | – | – | – |
| Cash flow to debt | – | -1,172.5% | – | – | – | – | – | – | – | – | – | – |
| Goodwill / Assets | – | 37.3% | – | – | – | – | – | – | – | – | – | – |
| Intangibles to total assets | – | 82.0% | 15.7% | 9.1% | 5.7% | 5.8% | 5.3% | 4.4% | 5.8% | 8.4% | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -6.35 | -6.92 | -0.72 | -0.56 | -49.10 | -0.43 | -1.40 | -22.66 | -3.70 | -365.86 | -240.73 | – |
| EBITDA / Interest expense | – | – | – | – | – | – | – | – | -3.69 | -365.43 | -240.27 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | – | – | – | – | – | – | -365.71 | -240.40 | – |
| Per share | ||||||||||||
| Revenue per share | – | 0.0005 | – | – | – | – | – | – | – | – | – | – |
| EPS (basic) | -0.0080 | -0.0020 | -0.0030 | -0.0020 | 0.0010 | -0.0060 | -0.0010 | 0.0060 | -0.0020 | -0.0090 | -0.02 | – |
| EPS (diluted) | -0.0080 | -0.0020 | -0.0030 | -0.0020 | 0.00 | -0.0060 | -0.0010 | 0.0060 | -0.0020 | -0.0090 | -0.02 | – |
| Book value per share | -0.0003 | 0.0062 | 0.0041 | 0.0073 | 0.0098 | 0.0070 | 0.01 | 0.01 | 0.0070 | 0.0098 | 0.02 | – |
| Tangible book value per share | -0.0003 | -0.0018 | 0.0034 | 0.0066 | 0.0091 | 0.0063 | 0.01 | 0.01 | 0.0063 | 0.0089 | 0.01 | – |
| Cash per share | 0.0001 | 0.0004 | 0.0026 | 0.0038 | 0.0054 | 0.01 | 0.01 | 0.0063 | 0.0064 | 0.0074 | 0.01 | – |
| Operating cash flow per share | -0.0011 | -0.0018 | -0.0013 | -0.0017 | -0.0019 | -0.0017 | -0.0018 | -0.0016 | -0.0022 | -0.0063 | -0.0071 | – |
| Free cash flow per share | – | -0.0019 | – | – | – | -0.0017 | -0.0018 | – | – | -0.0063 | -0.0071 | – |
| CapEx per share | – | 0.0001 | – | – | – | 0.0000 | 0.0000 | – | – | 0.0000 | 0.0000 | – |
| Valuation at period end | ||||||||||||
| Market cap | $20.45M | $44.15M | $22.02M | $26.37M | $58.52M | $62.32M | $28.18M | $35.58M | $25.09M | $33.47M | – | – |
| Enterprise value | $20.22M | $42.75M | $19.92M | $24.03M | $52.22M | $55.59M | $24.92M | $32.29M | $23.07M | $29.66M | – | – |
| P/S | – | 97.9x | – | – | – | – | – | – | – | – | – | – |
| P/B | -80.5x | 8.1x | 9.9x | 6.6x | 11.0x | 17.3x | 4.3x | 4.9x | 6.9x | 12.5x | – | – |
| P/TBV | -80.5x | -28.1x | 12.0x | 7.3x | 11.8x | 19.3x | 4.6x | 5.2x | 7.7x | 13.8x | – | – |
| P/Gross profit | – | 14,718x | – | – | – | – | – | – | – | – | – | – |
| P/OCF | -19.9x | -27.3x | -31.1x | -29.3x | -55.8x | -73.3x | -31.0x | -43.6x | -22.3x | -19.3x | – | – |
| EV/Sales | – | 94.8x | – | – | – | – | – | – | – | – | – | – |
| EV/Gross profit | – | 14,251x | – | – | – | – | – | – | – | – | – | – |
| EV/OCF | -19.7x | -26.4x | -28.2x | -26.7x | -49.8x | -65.4x | -27.4x | -39.6x | -20.5x | -17.1x | – | – |
| FCF yield | – | -3.8% | – | – | – | -1.4% | -3.2% | – | – | -5.2% | – | – |
| Shareholder yield | ||||||||||||
| Debt paydown yield | – | 0.03% | – | – | – | – | – | – | – | – | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | – | 3.5% | – | – | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | – | 58.5% | – | – | – | – | – | – | – | – | – | – |
| Per employee | ||||||||||||
| Total employees | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Revenue per employee | – | $451.00K | – | – | – | – | – | – | – | – | – | – |
| Gross profit per employee | – | $3.00K | – | – | – | – | – | – | – | – | – | – |
| Operating profit per employee | -$562.67K | -$775.00K | -$765.00K | -$880.00K | -$1.03M | -$948.00K | -$842.00K | -$793.00K | -$1.25M | -$1.28M | -$1.20M | – |
| Net income per employee | – | – | – | – | – | – | – | – | – | – | $667 | – |
| Free cash flow per employee | – | -$1.67M | – | – | – | -$851.00K | -$910.00K | – | – | -$867.00K | -$621.00K | – |
| Growth | ||||||||||||
| EBIT 1Y growth | -117.8% | -1.3% | 13.1% | 14.6% | -8.8% | -12.6% | -6.2% | 36.4% | 51.3% | 29.1% | – | – |
| EBITDA 1Y growth | – | – | – | – | – | – | – | – | 51.3% | 29.0% | – | – |
| Diluted EPS 1Y growth | -300.0% | 33.3% | -50.0% | – | 100.0% | -500.0% | -116.7% | 400.0% | 77.8% | 47.1% | – | – |
| Operating cash flow 1Y growth | 36.7% | -128.9% | 21.5% | 14.1% | -23.4% | 6.4% | -11.3% | 27.5% | 35.0% | 6.9% | – | – |
| Free cash flow 1Y growth | – | – | – | – | – | 6.5% | – | – | – | 6.9% | – | – |
| CapEx 1Y growth | – | – | – | – | – | -50.0% | – | – | – | 0.00% | – | – |
| CapEx 3Y CAGR | – | – | – | – | – | – | 0.00% | – | – | – | – | – |
| CapEx 5Y CAGR | – | 93.3% | – | – | – | -12.9% | – | – | – | – | – | – |
| Total assets 1Y growth | -98.1% | 252.4% | -42.0% | -36.7% | 1.8% | -9.8% | -15.9% | 30.2% | 118.3% | – | – | – |
| Total assets 3Y CAGR | -65.9% | 8.9% | -28.0% | -16.6% | -8.3% | -0.42% | 33.7% | – | – | – | – | – |
| Total assets 5Y CAGR | -52.0% | 3.5% | -22.3% | -8.7% | 17.0% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.